Medicare Enrolled
Dr. Srisha Rao, M.D.
Cardiovascular Disease · Ocala, FL
Practice pattern: Cardiac & Remote
— Practice combining cardiac and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rao?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rao
Dr. Srisha Rao is a cardiovascular disease specialist in Ocala, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rao performed 14,508 Medicare services across 8,675 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rao received a total of $8,691 from 38 pharmaceutical and/or device companies across 357 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rao is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in FL
$8,691 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 73544 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗14,508
Medicare services
Top 3% in FL for cardiovascular disease
8,675
Unique beneficiaries
$130
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~725 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,758 | $89 | $233 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,636 | $43 | $108 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,537 | $61 | $160 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
1,172 | $135 | $391 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 772 | $312 | $800 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
719 | $15 | $49 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
551 | $20 | $62 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
493 | $4 | $11 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
478 | $8 | $24 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
459 | $53 | $142 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
459 | $28 | $71 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
386 | $2,059 | $4,835 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
383 | $139 | $342 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
341 | $54 | $141 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
262 | $10 | $36 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
253 | $20 | $53 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
212 | $20 | $53 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
209 | $104 | $275 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
192 | $63 | $149 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
172 | $24 | $98 |
| Physician review of home INR testing A physician reviews, interprets, and manages home INR testing results for patients with mechanical heart valves, chronic atrial fibrillation, or venous thromboembolism who meet Medicare coverage criteria. |
163 | $7 | $19 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
127 | $100 | $332 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
124 | $170 | $215 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
115 | $47 | $164 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
106 | $71 | $220 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
63 | $325 | $898 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
58 | $48 | $121 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
58 | $63 | $180 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
55 | $40 | $82 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
53 | $77 | $194 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
47 | $20 | $52 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $125 | $320 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
19 | $63 | $202 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
18 | $140 | $394 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $138 | $360 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
12 | $38 | $72 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.5% high complexity
18.5% medium
60.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,691
Total received (2018-2024)
Avg $1,242/year across 7 years
Top 28% in FL for cardiovascular disease
38
Companies
357
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,691 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,684
2023
$1,695
2022
$1,586
2021
$1,393
2020
$569
2019
$664
2018
$1,100
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$990
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$867
Janssen Pharmaceuticals, Inc
$770
Novartis Pharmaceuticals Corporation
$618
Boston Scientific Corporation
$530
Impulse Dynamics (USA) Inc.
$466
Abbott Laboratories
$387
Amarin Pharma Inc.
$381
Boehringer Ingelheim Pharmaceuticals, Inc.
$358
Amgen Inc.
$355
AstraZeneca Pharmaceuticals LP
$317
Merck Sharp & Dohme LLC
$286
Stryker Corporation
$253
E.R. Squibb & Sons, L.L.C.
$234
Lexicon Pharmaceuticals, Inc.
$222
BIOTRONIK INC.
$185
Kestra Medical Technology Services, Inc.
$167
Alnylam Pharmaceuticals Inc.
$157
Astellas Pharma US Inc
$154
Philips Electronics North America Corporation
$146
CVRx, Inc.
$143
SANOFI-AVENTIS U.S. LLC
$109
Esperion Therapeutics, Inc.
$88
ATRICURE, INC.
$83
Medtronic, Inc.
$57
Allergan Inc.
$55
Regeneron Healthcare Solutions, Inc.
$47
Medtronic Vascular, Inc.
$45
BOSTON SCIENTIFIC CORPORATION
$32
Novo Nordisk Inc
$30
Merck Sharp & Dohme Corporation
$29
Edwards Lifesciences Corporation
$24
Philips North America LLC
$23
Bayer HealthCare Pharmaceuticals Inc.
$21
AngioDynamics, Inc.
$17
ARALEZ PHARMACEUTICALS US INC.
$16
Cleerly, Inc.
$15
Lundbeck LLC
$13
Top 3 companies account for 30.2% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (CK4) MCOT · ATRICLIP LAA EXCLUSION SYSTEM · Acticor · Armada 35 percutaneous catheter · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · Claria MRI · Cleerly Labs · Corlanor · DUPIXENT · ELIQUIS · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · Inpefa · JARDIANCE · JOT DX · Kerendia · LEQVIO · LEXISCAN · LINQ II · LUX-DX · LifeVest · MAKO · MITRACLIP · MULTAQ · NEXLETOL · NORTHERA · No Associated Product · ONPATTRO · Optimizer · Optimizer Smart System · Ozempic · PK Papyrus · PRADAXA · PRALUENT · RYBELSUS · Repatha · SQRX PULSE GENERATOR · Spectranetics Undiv · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · VenaCure 1470 Pro · WATCHMAN · WATCHMAN Access System · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $60 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
53
Per 100K population
13.7
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rao is a cardiac & remote specialist, with above-average Medicare volume (top 3% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rao experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rao performed 2,758 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rao receive payments from pharmaceutical companies?
Yes. Dr. Rao received a total of $8,691 from 38 companies across 357 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rao's costs compare to other cardiologists in Ocala?
Dr. Rao's average Medicare payment per service is $130. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Ocala
Browse cardiologists in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in FL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in FL
Which FL cardiologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology